DekaBank Deutsche Girozentrale
BankPosition in DNLI — Denali Therapeutics Inc.
CIK 1456228
FRANKFURT, 2M
Position in DNLI
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,130
-$1,147,030 QoQ
Shares Held
59,800
0.0% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#262
of 290 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DekaBank Deutsche Girozentrale holds $122,810,940 across 48 Biotechnology names. DNLI ranks #28 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
|
481,397 | $44,793,990 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
113,193 | $34,074,488 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
280,330 | $16,040,482 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
100,000 | $7,448,000 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
93,807 | $7,437,957 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
8,000 | $4,295,600 | |
| 7 | CAI |
Caris Life Sciences, Inc.
|
146,100 | $2,603,502 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
39,000 | $2,354,040 |
All Filings in DNLI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,130 | 59,800 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $1,148,160 | 59,800 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $1,350 | 59,800 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $868,296 | 59,800 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $836,602 | 59,800 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $872,934 | 64,210 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $1,218,724 | 59,800 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $1,741,974 | 59,800 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $1,388,556 | 59,800 | Shares | Defined | 2024-08-08 | |
| 2023-12-31 | $1,377,946 | 64,210 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $1,324,652 | 64,210 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,764,698 | 59,800 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $1,377,792 | 59,800 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $1,663,038 | 59,800 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $1,835,262 | 59,800 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $1,759,914 | 59,800 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $1,923,766 | 59,800 | Shares | Defined | 2022-04-28 | |
| 2021-12-31 | $2,426,240 | 54,400 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $2,668,805 | 52,900 | Shares | Defined | 2021-10-22 | |
| 2021-06-30 | $4,149,476 | 52,900 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $2,164,090 | 37,900 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $3,174,504 | 37,900 | Shares | Defined | 2021-03-12 | |
| 2020-09-30 | $1,282,714 | 35,800 | Shares | Defined | 2020-10-29 | |
| No filing history on record for this holder in this stock. | ||||||